tradingkey.logo

Pennant Group jumps after Truist upgrades on growth outlook

ReutersDec 2, 2025 5:00 PM

Shares of home health care provider Pennant Group PNTG.O rise 3.22% in early trading session

Truist Securities upgrades PNTG to "buy" from "hold", citing solid operating trends, strong sector demand and reduced reimbursement risk after a favorable 2026 home health rule

The 2026 Medicare payment rates and policies from U.S. regulators for home health providers is less restrictive than expected, easing concerns over Medicare reimbursement for home health providers, brokerage says

Brokerage also raised PT to $34 from $28, a 19.7% upside to stock's last close

Truist analysts said the integration of Pennant’s $146.5 million acquisition of 54 Amedisys locations is progressing smoothly and margins are expected to normalize post-investment

6 of 6 brokerages rate the stock "strong buy" or "buy"; median PT is $35 — data compiled by LSEG

Including current session, PNTG up 10.54% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI